Cargando…
8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis
BACKGROUND: Breast cancer is a heterogeneous disease that is not totally eradicated by current therapies. The classification of breast tumors into distinct molecular subtypes by gene profiling and immunodetection of surrogate markers has proven useful for tumor prognosis and prediction of effective...
Autores principales: | Rodrigues-Ferreira, Sylvie, Di Tommaso, Anne, Dimitrov, Ariane, Cazaubon, Sylvie, Gruel, Nadège, Colasson, Hélène, Nicolas, André, Chaverot, Nathalie, Molinié, Vincent, Reyal, Fabien, Sigal-Zafrani, Brigitte, Terris, Benoit, Delattre, Olivier, Radvanyi, François, Perez, Franck, Vincent-Salomon, Anne, Nahmias, Clara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749209/ https://www.ncbi.nlm.nih.gov/pubmed/19794912 http://dx.doi.org/10.1371/journal.pone.0007239 |
Ejemplares similares
-
The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer
por: Louis, Simon N.S., et al.
Publicado: (2011) -
AT2 Receptor-Interacting Proteins ATIPs in the Brain
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2013) -
The Tumor Suppressor MTUS1/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair
por: Ranjan, Nikhil, et al.
Publicado: (2021) -
Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer
por: Haykal, Maria M., et al.
Publicado: (2021) -
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study
por: Rogler, Anja, et al.
Publicado: (2014)